Search

Your search keyword '"Fabiola Traina"' showing total 81 results

Search Constraints

Start Over You searched for: Author "Fabiola Traina" Remove constraint Author: "Fabiola Traina" Language english Remove constraint Language: english
81 results on '"Fabiola Traina"'

Search Results

1. NT157 exhibits antineoplastic effects by targeting IRS and STAT3/5 signaling in multiple myeloma

2. Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia

Catalog

Books, media, physical & digital resources

3. Early death and intracranial hemorrhage prediction in acute promyelocytic leukemia: validation of a risk score in a chemotherapy plus ATRA cohort from an international consortium

4. Prognostic implications of ΔNp73/TAp73 expression ratio in core-binding factor acute myeloid leukemia

6. Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry

7. Isolated massive histiocytes renal interstitial infiltration: a case report of an unexpected cause of acute kidney injury in a kidney transplant recipient

8. NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells

9. ABSENT CD33 IN AML PATIENTS: FROM DIAGNOSIS TO FOLLOW-UPS

10. MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model

11. Molecular-Based Score inspired on metabolic signature improves prognostic stratification for myelodysplastic syndrome

12. T084: Treatment patterns and outcomes for Hodgkin’s Lymphoma (HL) patients (pts) aged 60 and older: a report from the Brazilian Prospective Hodgkin’s lymphoma Registry

13. P018: Treatment outcomes in classical Hodgkin lymphoma (HL): 5-year update report from the Brazilian Prospective Registry

14. The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study

15. Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells

16. Insulin Substrate Receptor (IRS) proteins in normal and malignant hematopoiesis

18. Paclitaxel induces Stathmin 1 phosphorylation, microtubule stability and apoptosis in acute lymphoblastic leukemia cells

19. PTK2 and PTPN11 expression in myelodysplastic syndromes

20. Tissue factor-dependent coagulation activation by heme: A thromboelastometry study.

22. Low bone mass density is associated with hemolysis in brazilian patients with sickle cell disease

23. Screening for hotspot mutations in PI3K, JAK2, FLT3 and NPM1 in patients with myelodysplastic syndromes

24. Myelodysplastic syndrome with synchronous gastric cancer: when the symptoms suggest something else

26. Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea

27. Elevated hypercoagulability markers in hemoglobin SC disease

28. Conventional chemotherapy for acute myeloid leukemia: a Brazilian experience

30. CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12.

31. SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype

32. A case of mistaken identity: When lupus masquerades as primary myelofibrosis

33. Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia

34. Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis.

35. Participation of Mac-1, LFA-1 and VLA-4 integrins in the in vitro adhesion of sickle cell disease neutrophils to endothelial layers, and reversal of adhesion by simvastatin

36. Acute myeloid leukemia with e1a2 BCR-ABL1 fusion gene: two cases with peculiar molecular and clinical presentations

40. Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia

41. Autophagy and inflammasome activation are associated with poor response to FLT3 inhibitors in patients with FLT3-ITD acute myeloid leukemia

42. MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model

43. METFORMINA IN VITRO INDUZ APOPTOSE E INIBE A VIA JAK/STAT EM MODELOS DE NEOPLASIA COM MUTAÇÃO CSF3R T618I

44. ARHGAP6 EXPRESSION IS ASSOCIATED WITH MOLECULAR RISK AND IMPACTS CLINICAL OUTCOMES IN ACUTE MYELOID LEUKEMIA

45. Molecular-Based Score inspired on metabolic signature improves prognostic stratification for myelodysplastic syndrome

46. ISCHEMIC STROKE IN PATIENTS WITH PHILADELPHIA-NEGATIVE CLASSICAL MYELOPROLIFERATIVE NEOPLASMS: EPIDEMIOLOGY AND RISK FACTORS IN A SINGLE CENTER INSTITUTION

47. Integrating clinical features with genetic factors enhances survival prediction for adults with acute myeloid leukemia

48. SIVA, a target of p53, is downregulated in myelodysplastic syndromes

49. ASSOCIATION OF NATURAL KILLER CELLS FUNCTIONAL SUBTYPES WITH GENETIC RISK STRATIFICATION IN ACUTE MYELOID LEUKEMIA

50. INIBIÇÃO FARMACOLÓGICA DE EZRINA REDUZ A VIABILIDADE, A CLONOGENICIDADE E A ATIVAÇÃO DA VIA PI3K/AKT/MTOR EM MODELOS CELULARES DE LEUCEMIA MIELOIDE AGUDA